Compare ARYX Therapeutics vs Momenta Pharmaceuticals
Customers evaluate the quality of ARYX Therapeutics's products using the following success metrics.
Overview
ARYX Therapeutics is 27 yrs old and is based in United States.
ARYx Therapeutics is a privately-held pharmaceutical research and development company focused on addressing safety concerns in well-established and commercially successful existing therapies through application of its proprietary ARYx RetroMetabolic (ARM) drug design. ARYx improves today's drugs, making proven therapies safer. ARYx currently has three products in clinical trials. For more information, please see the company's web site at www.aryx.com.
Momenta Pharmaceuticals is 23 yrs old and is based in United States.
Momenta Pharmaceuticals (NASDAQ: MNTA) is a biotechnology company with a validated scientific platform focused on discovering and developing biologic therapeutics to treat rare immune-mediated diseases and advancing its late stage biosimilars. On August 19th, 2020, Momenta Pharmaceuticals was acquired by Johnson & Johnson.5B.
Demo Video
Leadership
Peter G. Milner (Founder)
Alan Crane (Chief Executive Officer)
Investors
MPM Capital, OrbiMed Advisors
Johnson & Johnson, Polaris Partners
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because ARYX Therapeutics has not claimed their profile.
Work for ARYX Therapeutics? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for ARYX Therapeutics?
Claim your profile now.
Information not available because Momenta Pharmaceuticals has not claimed their profile.
Work for Momenta Pharmaceuticals? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Momenta Pharmaceuticals?
Claim your profile now.